Pradeep Chaluvally Raghavan, PhDM.D. Anderson Cancer Center Unraveling the oncogenic effects of amplified miRNAs in High Grade Serous Epithelial Ovarian Cancer Cancer cells are abnormal partly by having increased copies of certain genes (DNA copy number aberrations), which is an important hallmark of high-grade serous ovarian cancer. Non-protein coding genes such as microRNAs have recently […]
Read More
Pratip K Bhattacharya, PhDM.D. Anderson Cancer Center […]
Read MoreStarting April 1, 2025, the Rivkin Center’s ovarian cancer research funding, global symposium and fundraising activities will continue under the leadership of Ovarian Cancer Research Alliance (OCRA).
